arriv
accur
viru
diagnosi
clinic
inform
alon
unreli
case
except
includ
set
known
epidem
larg
number
case
may
present
similar
clinic
pictur
smallpox
erad
campaign
photograph
distinct
rash
smallpox
distribut
allow
field
worker
institut
immedi
contain
measur
howev
accur
viru
diagnosi
nearli
alway
requir
laboratori
test
past
decad
seen
major
revolut
oper
viru
diagnost
laboratori
role
clinic
manag
patient
becom
vital
driven
number
factor
develop
molecular
technolog
way
make
access
diagnost
laboratori
plethora
new
antivir
agent
sophist
understand
use
increas
awar
clinic
valu
demand
prompt
inform
viral
load
viral
sequenc
data
antivir
resist
inform
modern
viru
diagnost
laboratori
character
high
test
throughput
rapid
turnaround
time
close
liaison
clinic
staff
mani
older
slower
diagnost
approach
anim
inocul
viru
isol
cell
cultur
serolog
demonstr
fourfold
rise
antibodi
titer
minor
import
practic
appropri
manag
patient
depend
knowledg
follow
diagnosi
specif
manag
alway
includ
stop
chemotherapi
rapid
specif
accur
diagnosi
often
avoid
need
unnecessari
test
limit
unnecessari
continu
antibiot
use
eg
case
mening
ensur
quicker
manag
patient
allow
inform
prognosi
save
cost
furthermor
specif
activ
manag
measur
may
indic
manag
needlestick
injuri
medic
staff
screen
donat
organ
transplant
applic
blood
isol
precaut
particular
surgic
procedur
highli
depend
test
bloodborn
virus
cesarean
section
may
advis
woman
primari
genit
herp
time
deliveri
special
care
educ
requir
babi
congenit
defect
attribut
rubella
cytomegaloviru
pregnanc
termin
recommend
rubella
diagnos
first
trimest
pregnanc
use
antivir
agent
usual
requir
accur
laboratori
identif
infect
viru
chronic
diseas
exampl
caus
hiv
hepat
b
viru
decis
initi
therapi
requir
full
understand
clinic
laboratori
find
drug
combin
appropri
patient
select
later
modifi
base
drug
resist
profil
infect
viru
strain
result
viru
load
test
use
monitor
respons
therapi
guid
chang
therapi
infect
may
demand
public
health
measur
prevent
spread
other
instanc
blood
bank
routin
screen
hiv
hepat
b
c
virus
may
present
blood
donat
symptomless
carrier
sinc
herp
simplex
viru
type
readili
transmiss
sexual
partner
set
contact
trace
help
protect
sexual
partner
nosocomi
infect
eg
varicella
measl
often
epidem
form
may
creat
havoc
leukemia
ward
children
hospit
unless
hyperimmun
igg
promptli
administ
potenti
contact
follow
diagnosi
sentinel
case
document
novel
strain
influenza
viru
may
herald
start
major
epidem
vulner
older
member
commun
immun
posit
identif
particular
arboviru
case
enceph
enabl
author
promulg
warn
initi
appropri
mosquito
control
measur
introduct
danger
exot
diseas
demand
contain
surveil
surveil
viral
infect
may
shed
light
signific
natur
histori
preval
viru
commun
allow
control
measur
laboratori
diagnosi
viru
diseas
design
control
prioriti
establish
immun
program
monitor
evalu
virusdiseas
associ
continu
discov
everi
year
stress
human
virus
known
today
complet
unknown
end
world
war
ii
opportun
legion
astut
clinician
well
pathologist
virologist
epidemiologist
instrument
discoveri
tradit
approach
laboratori
diagnosi
viral
infect
direct
detect
patient
materi
virion
viral
antigen
viral
nucleic
acid
isol
viru
cultur
cell
follow
identif
isol
detect
measur
antibodi
patient
serum
serolog
recent
decad
direct
detect
method
capabl
provid
definit
answer
less
hour
undergon
major
advanc
wherea
viru
serolog
becom
restrict
particular
purpos
viru
isol
use
infrequ
outsid
research
specialist
area
summari
major
strength
limit
sever
altern
approach
diagnosi
viral
infect
given
tabl
best
diagnost
method
satisfi
criteria
speed
simplic
sensit
specif
cost
standard
diagnost
reagent
reliabl
qualiti
wide
chanc
success
diagnosi
viru
isol
direct
detect
viru
depend
critic
attent
given
attend
physician
collect
sampl
clearli
clinic
sampl
must
taken
right
place
right
time
right
time
soon
possibl
patient
first
present
viru
usual
present
maximum
concentr
time
symptom
first
develop
declin
ensu
day
sampl
taken
last
resort
day
week
empir
treatment
eg
antibiot
therapi
almost
invari
useless
site
specimen
collect
depend
clinic
symptom
sign
togeth
knowledg
pathogenesi
suspect
diseas
gener
rule
epitheli
surfac
constitut
portal
entri
primari
site
viral
replic
usual
best
site
obtain
sampl
tabl
key
specimen
respiratori
infect
well
mani
gener
infect
nasal
throat
swab
case
young
child
nasopharyng
aspir
mucu
drawn
back
nose
throat
mucu
trap
use
vacuum
pump
sampl
fece
also
essenti
enter
mani
gener
infect
gastrointestin
tract
swab
may
taken
genit
tract
eye
vesicular
skin
lesion
virus
respons
system
infect
isol
blood
plasma
leukocyt
cerebrospin
fluid
csf
may
yield
viru
case
mening
enceph
biopsi
autopsi
specimen
may
taken
needl
knife
part
bodi
viru
isol
snapfrozen
immunofluoresc
obvious
tissu
taken
autopsi
biopsi
purpos
viru
isol
must
place
formalin
fix
case
mani
gener
viral
diseas
may
obviou
specimen
requir
rough
work
rule
said
suffici
earli
stage
diseas
viru
usual
isol
throat
swab
fece
blood
case
essenti
captur
suffici
patient
materi
prefer
moisten
swab
neg
diagnos
expect
medic
attend
fail
collect
enough
materi
patient
labil
mani
virus
specimen
intend
viru
isol
must
alway
kept
cold
moist
immedi
collect
swab
swirl
around
small
screwcap
bottl
contain
viru
transport
medium
medium
consist
buffer
balanc
salt
solut
ad
protein
eg
gelatin
albumin
protect
viru
inactiv
antibiot
prevent
multipl
bacteria
fungi
probabl
specimen
also
use
attempt
isol
bacteria
rickettsia
chlamydia
mycoplasma
collect
medium
must
contain
antibioticsth
portion
use
viru
isol
treat
antibiot
later
swab
stick
broken
asept
fluid
cap
tightli
fasten
secur
adher
tape
prevent
leakag
bottl
label
patient
name
date
collect
natur
specimen
dispatch
immedi
laboratori
accompani
complet
laboratori
request
form
must
includ
adequ
clinic
histori
provision
diagnosi
request
particular
test
date
onset
ill
transit
time
hour
anticip
contain
sent
refriger
frozen
cold
pack
ice
thermo
flask
styrofoam
box
intern
interst
transport
specimen
particularli
hot
weather
gener
requir
contain
pack
dri
ice
solid
co
maintain
nucleic
acid
test
revolution
diagnost
virolog
sensit
nucleic
acid
assay
mean
previous
unsuit
specimen
use
eg
deep
nasal
swab
throat
swab
examin
respiratori
virus
instead
requir
nasal
pharyng
aspir
tracheal
aspir
addit
qualiti
collect
less
import
selfcollect
suitabl
human
papilloma
viru
test
transport
less
critic
nucleic
acid
viral
particl
rel
stabl
eg
respiratori
sampl
vtm
sent
mail
dri
blood
spot
use
nucleic
acid
test
increas
rang
detect
virus
side
test
specif
suspect
viru
consequ
variant
may
miss
unless
assay
design
inclus
direct
detect
viru
materi
patient
sampl
becom
method
choic
larg
number
differ
infect
method
advantag
speed
reli
viru
cultur
rise
antibodi
titer
sensit
specif
antigen
detect
method
increas
greatli
use
highqual
reagent
solid
phase
reagent
support
allow
eas
wash
signal
detect
sensit
nucleic
acid
detect
advanc
earli
dot
blot
southern
blot
assay
widespread
reliabl
use
pcr
morpholog
virus
suffici
characterist
allow
assign
mani
virus
correct
famili
appear
electron
microscop
moreov
virus
never
cultur
may
nevertheless
recogn
electron
microscopi
mean
discoveri
fece
sever
new
group
previous
noncultiv
virus
human
rotavirus
calicivirus
astrovirus
hepat
viru
previous
unknown
type
adenovirus
coronavirus
initi
identifi
way
wide
use
procedur
neg
stain
viruscontain
fluid
place
carbon
formvarco
grid
usual
prior
clarif
concentr
ultracentrifug
virion
adher
surfac
becom
neg
stain
electrondens
fluid
sodium
phosphotungst
ad
surround
virion
sever
variat
method
mainli
remov
excess
salt
protein
affect
transluc
specimen
microscop
characterist
virion
size
structur
detail
provid
use
inform
toward
viru
identif
routin
diagnost
approach
fail
preincub
viru
specimen
specif
antibodi
use
assist
viru
identificationantibodyco
virion
appear
fuzzier
control
see
fig
procedur
immun
electron
microscopi
also
use
quantit
specif
antibodi
second
procedur
thinsect
electron
microscopi
fix
tissu
section
use
particularli
research
set
exampl
virallik
inclus
suggest
viral
etiolog
patholog
particular
diseas
investig
biggest
limit
electron
microscopi
diagnost
tool
low
sensit
specimen
need
contain
least
virion
per
millilit
milligram
chanc
detect
viru
electron
microscopi
level
often
surpass
fece
vesicl
fluid
respiratori
mucu
method
quick
one
sever
sampl
impract
larg
batch
test
great
varieti
differ
immunolog
assay
use
detect
viral
antigen
patient
sampl
use
wellcharacter
reagent
contain
known
antibodi
specif
antigencontain
reagent
defin
assay
techniqu
use
similarli
detect
unknown
antibodi
see
introduct
eia
also
known
elisa
enzymelink
immunosorb
assay
revolution
diagnost
virolog
day
develop
polymeras
chain
reaction
pcr
still
widespread
specif
use
eia
design
differ
format
detect
antigen
antibodi
high
sensit
method
mean
less
viral
antigen
per
millilit
detect
specimen
taken
directli
patient
develop
solidphas
assay
major
technic
advanc
avail
test
configur
almost
limitless
wide
varieti
direct
indirect
revers
assay
develop
diagnos
viral
infect
critic
principl
compon
make
layer
reaction
known
defin
except
unknown
compon
may
present
specimen
solidphas
format
captur
antibodi
attach
simpl
adsorpt
coval
bond
solid
substrat
typic
well
polystyren
polyvinyl
microtit
plate
polystyren
bead
format
aid
consider
rins
solid
surfac
applic
reagent
simplest
format
direct
eia
fig
viru
solubl
viral
antigen
specimen
allow
adsorb
captur
antibodi
unbound
antigen
wash
away
enzymelabel
antivir
antibodi
detector
antibodi
ad
variou
enzym
link
antibodi
horseradish
peroxidas
alkalin
phosphatas
commonli
use
final
wash
step
readout
base
color
chang
follow
addit
appropri
organ
substrat
particular
enzym
color
product
action
enzym
substrat
clearli
seen
eye
test
made
quantit
serial
dilut
antigen
obtain
endpoint
use
spectrophotometri
measur
amount
enzymeconjug
antibodi
bound
captur
antigen
sensit
enhanc
use
high
bind
affin
avidin
biotin
antibodi
conjug
biotin
reagent
low
r
give
reproduc
label
alter
antigenbind
capac
detector
antibodi
antigenantibodi
complex
identifi
ad
avidinlabel
enzym
follow
enzym
substrat
fig
right
increas
sensit
highenergi
substrat
avail
releas
fluoresc
chemiluminesc
radioact
product
identifi
small
amount
indirect
immunoassay
wide
use
somewhat
greater
sensit
avoid
need
label
antivir
antibodi
laboratori
repertoir
one
protocol
detector
antibodi
unlabel
layer
label
speciesspecif
antiimmunoglobulin
ad
indic
antibodi
cours
viral
antibodi
constitut
captur
detector
antibodi
must
rais
differ
anim
speci
altern
detector
antibodi
label
biotin
posit
reaction
indic
use
enzymelabel
avidin
anoth
method
label
staphylococc
protein
bind
fc
moieti
igg
mammalian
speci
use
indic
indirect
immunoassay
monoclon
viral
antibodi
mab
frequent
use
immunoassay
detector
antibodi
use
mab
captur
antibodi
limit
restrict
epitop
repertoir
recogn
clone
antibodi
molecul
thu
antigen
captur
less
stabl
obviou
advantag
mab
repres
wellcharacter
purifi
monospecif
antibodi
defin
class
recogn
singl
epitop
well
free
natur
extran
antibodi
host
antigen
adventiti
agent
monoclon
antibodi
also
make
vital
contribut
refer
reagent
easili
manufactur
larg
quantiti
import
select
mab
high
affin
high
specif
strain
viru
sought
might
miss
assay
inde
specif
assay
predetermin
select
mab
direct
epitop
either
confin
particular
viral
serotyp
common
serotyp
within
given
speci
genu
radioimmunoassay
ria
predat
eia
signific
differ
label
enzym
radioact
isotop
bound
antibodi
measur
gamma
counter
ria
highli
sensit
reliabl
assay
lend
well
autom
cost
equip
health
hazard
work
radioisotop
argu
use
small
laboratori
timeresolv
fluoresc
immunoassay
trfia
nonisotop
immunoassay
indic
antibodi
label
fluorophor
europium
chelat
follow
excit
light
fluorophor
emit
fluoresc
differ
wavelength
measur
timelaps
fluoromet
method
sensit
ria
advantag
stabl
fluorophor
requir
costli
equip
contempl
laboratori
larg
throughput
specimen
perhap
simplest
immunoassay
agglutin
antigen
small
latex
bead
previous
coat
antivir
antibodi
test
read
eye
within
minut
surprisingli
diagnost
kit
base
method
becom
popular
small
laboratori
medic
practition
howev
assay
suffer
low
sensit
low
specif
thu
fals
neg
occur
unless
larg
number
virion
present
therefor
assay
antigen
tend
restrict
examin
fece
fals
posit
hand
occur
commonli
fecal
specimen
immunochromatographi
later
flow
test
involv
migrat
antigen
antigenantibodi
complex
support
exampl
nitrocellulos
film
filter
paper
agaros
typic
format
label
antibodi
allow
react
unknown
antigen
antigenantibodi
complex
migrat
capillari
action
solid
support
second
antibodi
embed
solid
support
allow
detect
complex
antigen
present
posit
neg
control
includ
ensur
individu
test
valid
immunochromatographi
test
avail
measur
viral
antigen
hiv
dengu
influenza
b
rsv
etc
particular
valu
rapid
pointofcar
test
rapid
result
need
access
equip
limit
viral
nonvir
antigen
detect
fix
frozen
tissu
section
exfoli
cell
use
principl
cell
tissu
glass
slide
fill
role
solid
support
commonli
use
indic
includ
fluorescein
horseradish
peroxidas
alkalin
phosphatas
approach
valuabl
viru
diagnosi
exampl
detect
viral
antigen
exfoli
cell
tissu
sampl
also
studi
diseas
pathogenesi
presenc
viral
materi
match
particular
organ
histopatholog
antibodi
label
fluorochrom
antigenantibodi
complex
emit
light
particular
longer
wavelength
excit
short
wavelength
light
visual
fluoresc
ordinari
microscop
light
wavelength
filter
sensit
method
gener
low
detect
complex
fluoresc
antibodi
virion
solubl
antigen
henc
antigen
test
typic
take
form
virusinfect
cell
two
main
variant
techniqu
direct
immunofluoresc
frozen
tissu
section
acetonefix
cell
smear
monolay
coverslip
incub
fluoresceintag
antivir
antibodi
fig
left
unbound
antibodi
wash
away
cell
view
light
microscopi
use
power
ultravioletblu
light
sourc
applegreen
light
emit
specimen
reveal
black
background
incorpor
filter
eyepiec
blue
ultraviolet
incid
light
adsorb
fig
indirect
sandwich
immunofluoresc
differ
antivir
antibodi
untag
fill
role
meat
sandwich
bind
antigen
recogn
fluoresceinconjug
antiimmunoglobulin
fig
right
high
affin
avidin
biotin
also
exploit
immunofluoresc
coupl
biotin
antibodi
fluorescein
avidin
diagnost
set
immunofluoresc
prove
great
valu
earli
identif
viral
antigen
infect
cell
taken
patient
diseas
known
rel
small
number
possibl
etiolog
agent
littl
difficulti
remov
partli
detach
infect
cell
mucou
membran
upper
respiratori
tract
genit
tract
eye
skin
simpli
swab
scrape
infect
area
reason
firm
cell
also
present
mucu
aspir
nasopharynx
aspir
cell
must
extens
wash
centrifug
remov
mucu
fixat
stain
respiratori
infect
paramyxovirus
orthomyxovirus
adenovirus
herpesvirus
particularli
amen
rapid
diagnosi
immunofluoresc
immunofluoresc
also
appli
infect
tissu
exampl
brain
biopsi
diagnosi
lethal
diseas
herp
simplex
enceph
measl
sspe
necropsi
verif
rabi
brain
anim
captur
bite
human
altern
method
locat
identifi
viral
antigen
infect
cell
use
antibodi
coupl
horseradish
peroxidas
subsequ
addit
hydrogen
peroxid
togeth
benzidin
deriv
form
color
insolubl
precipit
advantag
method
prepar
perman
ordinari
light
microscop
need
endogen
peroxidas
present
number
tissu
particularli
leukocyt
produc
fals
posit
problem
circumv
proper
techniqu
adequ
control
enzym
exampl
alkalin
phosphatas
also
use
indic
system
fig
nucleic
acid
detect
wide
appli
use
polymeras
chain
reaction
pcr
assay
combin
advanc
oligonucleotid
synthesi
standard
autom
procedur
nucleic
acid
extract
realtim
detect
pcr
product
rapid
advanc
nucleic
acid
sequenc
technolog
avail
sequenc
databas
greatli
enhanc
analysi
result
obtain
isotherm
rna
dna
amplif
assay
also
readili
avail
signal
amplif
assay
use
previous
supersed
time
develop
first
nucleic
acid
hybrid
techniqu
varieti
test
format
appli
viral
nucleic
acid
detect
earli
approach
usual
involv
hybrid
reaction
immobil
nucleic
acid
target
label
probe
wash
away
unbound
probe
follow
subsequ
detect
bound
probe
includ
dotblot
assay
use
nucleic
acidcontain
sampl
immobil
onto
filter
southern
blot
hybrid
viral
nucleic
acid
separ
electrophoresi
accord
molecular
weight
blot
filter
detect
hybrid
situ
hybrid
appli
infect
tissu
section
exfoli
cell
realtim
pcr
nowaday
often
use
hybrid
solut
part
product
detect
strategi
tradit
radioact
isotop
p
use
label
nucleic
acid
oligonucleotid
use
probe
hybrid
test
signal
read
count
spectromet
autoradiographi
larg
replac
nonradioact
label
eg
fluorescein
peroxidas
produc
signal
directli
wherea
other
eg
biotin
digoxigenin
act
indirectli
bind
anoth
label
ligand
emit
signal
biotinyl
probe
combin
variou
type
readout
exampl
avidinbas
eia
chemiluminesc
substrat
luminol
also
wide
exploit
pcr
fig
constitut
one
greatest
advanc
molecular
biolog
enabl
singl
copi
gene
sequenc
enzymat
amplifi
vitro
least
millionfold
within
hour
thu
viral
dna
extract
small
number
virion
infect
cell
amplifi
point
readili
identifi
pcr
also
use
detect
viral
rna
includ
preliminari
step
revers
transcriptas
use
convert
rna
dna
necessari
usual
amplifi
whole
genom
necessari
know
least
suffici
nucleotid
sequenc
order
synthes
two
oligonucleotid
primer
usual
residu
length
hybrid
opposit
strand
target
dna
flank
region
one
choos
amplifi
two
primer
sometim
known
forward
revers
primer
provid
dna
polymeras
initi
point
addit
nucleotid
attach
also
attach
reaction
specif
dna
target
region
primer
synthes
contain
attach
ligand
molecular
tag
therebi
gener
tag
dna
product
molecul
facilit
analysi
comput
program
use
design
optimum
primer
set
predict
optim
pcr
reaction
condit
exampl
timetemperatureion
condit
target
might
expect
show
variabl
particular
site
degener
primer
contain
differ
base
site
synthes
ensur
variant
detect
process
carri
care
control
condit
temperatur
ionic
strength
primer
concentr
nucleotid
concentr
three
main
step
melt
target
dna
cool
around
allow
bind
two
oligonucleotid
primer
synthesi
extens
oligonucleotid
primer
two
dna
strand
locat
includ
two
primer
thu
gener
complementari
copi
origin
plu
minu
target
strand
synthesi
reaction
catalyz
dna
polymeras
ad
reaction
primer
extens
product
first
cycl
act
templat
second
reaction
cycl
melt
primer
bind
primer
extens
repeat
mani
time
number
dna
copi
increas
exponenti
thu
cycl
number
dna
copi
begin
singl
copi
target
sequenc
theoret
billion
practic
million
achiev
forti
cycl
complet
less
hour
depend
reaction
volum
method
suitabl
autom
thermal
cycl
devic
amplifi
dna
may
detect
either
stain
band
correct
molecular
weight
agaros
gel
electrophoresi
hybrid
label
dna
rna
probe
culmin
wide
varieti
readout
system
howev
develop
realtim
detect
system
see
revolution
speed
quantit
accuraci
method
greatli
help
reduc
falseposit
reaction
due
contamin
select
suitabl
pair
primer
matter
critic
import
may
chosen
highli
specif
particular
viru
strain
altern
repres
consensu
sequenc
within
gene
known
conserv
within
given
famili
genu
probe
conserv
gene
rna
polymeras
even
possibl
discov
previous
unknown
agent
reaction
must
carri
care
control
condit
ionic
strength
temperatur
primer
concentr
nucleotid
concentr
deviat
result
nonspecif
amplif
pcr
technolog
undergon
numer
major
develop
sinc
first
descript
includ
use
heatstabl
dna
polymeras
taq
thermu
aquaticu
organ
natur
found
hot
spring
sinc
make
longer
necessari
replenish
enzym
cycl
reaction
tube
remain
seal
also
allow
use
higher
anneal
temperatur
therebi
increas
reaction
specif
reduc
falseposit
reaction
due
mismatch
use
nest
pcr
reaction
wherebi
second
amplif
carri
primer
intern
initi
target
initi
pcr
amplif
target
sequenc
greatli
increas
sensit
albeit
potenti
cost
increas
risk
falseposit
reaction
due
detect
trace
amount
dna
sequenc
extrem
sensit
earli
pcr
result
suffer
regular
problem
environment
contamin
dna
product
lead
falseposit
result
procedur
develop
reput
unreli
laboratori
went
heroic
effort
prevent
reaction
contamin
includ
stringent
physic
segreg
differ
step
procedur
becom
far
less
problem
recent
advanc
particular
use
realtim
detect
method
realtim
pcr
test
method
detect
pcr
product
requir
develop
thermocycl
inbuilt
fluorimet
allow
measur
newli
synthes
pcr
product
reaction
tube
accumul
real
time
reaction
product
detect
dye
fluoresc
bound
nonspecif
doublestrand
dna
exampl
sybr
green
sequencespecif
report
probe
egtaqman
contain
fluoresc
report
one
end
fluoresc
quencher
bind
specif
newli
synthes
target
sequenc
lead
loss
quench
emiss
quantit
fluoresc
signal
reaction
progress
intens
fluoresc
signal
continu
monitor
plot
gener
curv
posit
reflect
origin
concentr
target
approach
larg
replac
method
product
detect
requir
reaction
tube
open
reaction
start
therebi
minim
contamin
achiev
excel
quantit
measur
sensit
earlier
detect
system
sequencespecif
report
probe
use
improv
specif
target
sequenc
nonspecif
dna
molecul
detect
develop
accur
quantit
realtim
detect
method
allow
gener
standard
curv
posit
correspond
origin
concentr
target
unrel
copi
number
control
includ
reaction
detect
nonspecif
inhibit
enzym
reaction
number
infect
clinic
interpret
manag
depend
regular
quantit
patient
viral
load
use
multiplex
pcr
differ
fluoresc
probe
becam
avail
pcr
product
detect
becam
possibl
includ
differ
set
primer
bear
differ
fluoresc
label
differ
target
reaction
therebi
detect
number
differ
product
simultan
exploit
number
standard
protocol
specif
site
exampl
respiratori
viru
infect
fig
isotherm
amplif
method
variat
pcr
requir
high
temperatur
cycl
melt
newli
synthes
dna
product
allow
bind
new
round
primer
method
reli
enzym
displac
strand
includ
loop
mediat
isotherm
amplif
lamp
strand
displac
amplif
sda
helicasedepend
amplif
nick
enzym
amplif
reaction
near
method
potenti
advantag
extrem
fast
requir
thermal
cycl
equip
sever
exampl
avail
approv
diagnost
test
due
speed
sensit
versatil
pcr
method
detect
quantifi
viral
genom
approach
signific
part
routin
work
diagnost
laboratori
mani
commerci
test
system
avail
method
antigen
detect
viru
isol
tend
requir
differ
reagent
prepar
expertis
method
specif
individu
viru
wherea
pcr
technolog
univers
applic
specif
reli
primarili
chosen
primer
sequenc
procedur
invalu
deal
virus
cultur
satisfactorili
specimen
contain
predominantli
inactiv
viru
result
prolong
storag
transport
quantit
result
need
avoid
expos
laboratori
staff
cultur
larger
quantiti
biohazard
categori
agent
furthermor
easi
make
new
pcr
reagent
new
virus
therebi
rapidli
expand
capac
test
problem
may
encount
pcr
includ
clinic
sampl
may
contain
factor
inhibit
activ
dna
polymeras
lead
fals
low
neg
result
detect
test
parallel
sampl
control
contain
standard
unrel
dna
target
copi
number
control
possibl
contamin
reaction
extran
dna
origin
patient
although
nowaday
much
less
issu
method
specif
particular
viru
virus
contrast
openmind
procedur
viru
isol
electron
microscopi
pcr
detect
agent
recogn
primer
set
test
condit
thu
variant
virus
may
miss
sequenc
amplifi
sequenc
amplifi
detect
product
assay
system
use
extrem
sensit
pcr
mean
low
level
chronic
latent
concurr
infect
genom
unrel
patient
clinic
condit
may
detect
diagnost
procedur
final
ascrib
laboratori
find
patient
condit
patient
histori
physic
find
knowledg
diseas
pathogenesi
clinic
acumen
must
brought
play
exampl
varicella
zoster
viru
dna
detect
contamin
genit
herp
simplex
viru
infectionth
pcr
give
strong
weak
vzv
reaction
primer
use
anoth
technolog
advanc
impact
field
diagnost
use
microarray
microchip
nucleic
acid
detect
microchip
solid
support
matrix
onto
print
spot
contain
one
sever
hundr
sever
thousand
uniqu
oligonucleotid
oligonucleotid
repres
conserv
sequenc
virtual
virus
repres
variou
genet
databas
custom
repres
virus
given
specif
diseas
syndrom
acut
respiratori
diseas
children
basi
technolog
captur
oligonucleotid
randomli
amplifi
label
nucleic
acid
sequenc
clinic
specimen
bind
label
sequenc
detect
laser
scan
chip
softwar
program
assess
strength
bind
map
posit
react
oligonucleotid
softwar
identifi
viru
clinic
sampl
type
test
use
initi
determin
viru
respons
sever
acut
respiratori
syndrom
sar
coronaviru
knowledg
oligonucleotid
sequenc
bind
unknown
viru
primer
made
eventu
determin
entir
nucleotid
sequenc
viru
low
cost
oligonucleotid
synthesi
develop
laser
scan
devic
nucleic
acid
amplif
techniqu
softwar
develop
made
technolog
avail
special
refer
laboratori
increasingli
common
nation
diagnost
laboratori
network
microarray
technolog
use
research
tool
year
exampl
studi
comprehens
gene
express
cell
tissu
appli
increasingli
monitor
host
respons
infect
assess
develop
antivir
drug
resist
use
map
immun
respons
gene
express
hepat
cinfect
liver
tissu
chang
leukocyt
gene
express
patient
sepsi
also
directli
appli
diagnost
arena
exampl
commerci
microarray
avail
simultan
detect
larg
panel
respiratori
virus
react
product
multiplex
pcr
rtpcr
reaction
solid
chip
liquid
bead
platform
carri
oligonucleotid
probe
multipl
virus
similar
approach
describ
simultan
detect
type
human
papillomaviru
sequenc
routin
clinic
specimen
transfer
technolog
routin
diagnost
laboratori
still
present
challeng
least
due
requir
rapid
turnaround
highthroughput
qualityassur
procedur
diagnost
set
unpredict
heterogen
clinic
sampl
nevertheless
like
applic
microarray
technolog
eventu
lead
anoth
transform
diagnost
laboratori
deep
sequenc
nextgener
sequenc
refer
novel
techniqu
dna
sequenc
directli
dna
fragment
without
need
clone
vector
allow
gener
enorm
amount
sequenc
data
high
speed
low
cost
singl
run
number
system
commerci
avail
approach
yield
enorm
benefit
variou
research
field
applic
diagnost
virolog
explor
differ
platform
differ
advantag
pitfal
exampl
differ
read
length
read
depth
access
capabl
bioinformat
resourc
essenti
ensur
data
analysi
done
appropri
unbias
broadbas
analysi
nucleic
acid
clinic
sampl
sequenc
multiplex
platform
howev
host
sequenc
frequent
outnumb
infect
viru
sequenc
prior
select
enrich
viru
sequenc
achiev
exampl
hybrid
captur
use
pcrderiv
captur
probe
prior
pcr
amplif
suspect
viru
sequenc
unknown
target
sampl
physic
method
partial
purif
exampl
base
nucleas
resist
encapsid
viral
genom
approach
alreadi
appli
mani
purpos
virolog
exampl
full
applic
deep
sequenc
technolog
viru
diagnosi
yet
achiev
deep
sequenc
method
like
complement
exist
method
rather
replac
cost
plummet
enorm
allow
technolog
move
larg
institut
widespread
diagnost
set
howev
mani
develop
challeng
remain
includ
huge
comput
data
analysi
requir
creat
gener
enorm
amount
data
recent
year
viru
isol
chang
role
gold
standard
diagnost
laboratori
occupi
research
histor
role
newer
techniqu
particularli
sensit
antigen
eia
pcr
suffer
drawback
viru
isol
includ
high
cost
slow
fals
neg
due
viru
inactiv
transport
complex
antibodi
cell
line
lose
sensit
increas
concern
live
viru
transmiss
staff
mani
diagnost
laboratori
longer
tri
isol
virus
cell
cultur
viru
isol
cell
cultur
mostli
limit
research
laboratori
need
grow
larg
amount
viru
even
bulk
antigen
product
often
done
preferenti
express
recombin
antigen
unknown
agent
sought
use
molecular
techniqu
randomprim
pcr
similarli
techniqu
anim
inocul
exampl
suckl
mice
egg
inocul
procedur
perform
laboratori
specialist
need
exampl
influenza
viru
use
vaccin
product
grown
embryon
hen
egg
success
viru
isol
cell
cultur
follow
step
follow
care
must
given
maintain
cold
chain
patient
laboratori
care
freez
sampl
virus
labil
freez
detail
descript
viru
isol
reader
encourag
consult
detail
sourc
exampl
nation
refer
laboratori
inform
distribut
us
center
diseas
control
prevent
http
wwwcdcgov
world
health
organ
http
wwwwhoint
fig
routin
diagnost
purpos
usual
necessari
determin
exact
strain
sequenc
viru
detect
hand
certain
situat
inform
crucial
patient
manag
epidemiolog
public
health
purpos
serolog
method
includ
eia
neutral
viru
growth
use
identifi
differ
serotyp
assist
avail
appropri
monoclon
antibodi
fig
differ
influenza
viru
isol
character
compar
compar
hemagglutinationinhibit
titer
use
standard
antisera
complet
nucleotid
sequenc
viral
genom
often
attempt
diagnost
purpos
present
although
probabl
increasingli
widespread
next
year
howev
obtain
partial
sequenc
pcr
product
wide
use
replac
earlier
molecular
approach
restrict
map
dna
product
oligonucleotid
fingerprint
exampl
resist
patient
circul
hiv
commonli
use
antiretrovir
drug
predict
pattern
resistanceassoci
point
mutat
sequenc
viral
polymeras
determin
sequenc
patient
hiv
pcr
product
compar
commerci
avail
sequenc
databas
correl
polymeras
sequenc
drug
resist
phenotyp
result
use
plan
patient
individu
drug
regimen
modifi
drug
regimen
patient
viru
becom
resist
differ
rabi
viru
sequenc
variant
segreg
accord
geograph
region
anim
host
speci
sequenc
rabi
viru
recov
patient
use
determin
origin
infect
order
investig
appar
cluster
hiv
patient
may
may
acquir
infect
common
sourc
exampl
singl
medic
practic
surgeon
common
sexual
partner
partial
sequenc
virus
block
attachmentbind
antibodi
molecul
viru
result
steric
interfer
virusreceptor
bind
block
endocytosisantibodi
molecul
bind
capsid
alter
capsid
structur
affect
process
endocytosi
block
uncoatingantibodi
bound
incom
particl
fix
capsid
stabl
conform
phdepend
uncoat
possibl
block
uncoat
insid
cellantibodi
may
taken
endocytosi
interact
virion
insid
cell
infect
start
aggregationbecaus
antibodi
dival
aggreg
viru
particl
facilit
destruct
phagocyt
mechan
may
oper
quantit
neutral
assay
viru
neutral
assay
may
use
measur
titer
neutral
antibodi
clinic
sampl
react
standard
viru
inoculum
differ
dilut
serum
mani
variat
exampl
known
antisera
differ
viru
serotyp
may
use
identifi
serotyp
new
viru
isol
test
may
run
cell
cultur
cytopath
effect
plaqu
endpoint
anim
necessari
mani
step
may
autom
compar
usual
random
sequenc
variat
seen
popul
assess
likelihood
truli
repres
common
sourc
infect
identif
unknown
virus
viral
antigen
use
panel
antibodi
known
specif
alreadi
discuss
serolog
techniqu
may
employ
way
around
use
panel
known
antigen
identifi
unknown
antibodi
basic
principl
wide
use
today
set
tabl
fig
follow
tradit
approach
pair
sera
taken
patient
acutephas
serum
sampl
earli
possibl
ill
convalescentphas
sampl
least
day
later
blood
collect
absenc
anticoagul
given
time
clot
serum
separ
acut
convalesc
serum
sampl
test
simultan
certain
test
measur
inhibit
biolog
function
viru
exampl
viru
neutral
hemagglutinationinhibit
sera
must
first
inactiv
heat
minut
sometim
treat
addit
method
order
destroy
variou
type
nonspecif
inhibitor
infect
hemagglutin
respect
prior
treatment
serum
gener
requir
assay
simpli
measur
antigenantibodi
bind
eia
ria
western
blot
latex
agglutin
immunofluoresc
immunodiffus
pair
sera
titrat
antibodi
use
wide
rang
avail
serolog
techniqu
demonstr
signific
rise
antibodi
titer
convent
fourfold
rise
titrat
test
serum
twofold
dilut
taken
proof
seroconvers
acut
infect
agent
question
practic
mani
subtleti
interpret
result
exampl
time
collect
pair
sera
relat
date
onset
ill
must
care
assess
allow
inappropri
sampl
time
moreov
individu
immun
due
prior
infect
immun
may
undergo
second
reinfect
often
subclin
natur
show
rise
antibodi
titer
obviou
realiti
two
welltim
pair
sera
allow
demonstr
fourfold
rise
titer
often
avail
attempt
sometim
made
infer
recent
infect
occur
basi
one
serum
sampl
contain
rel
high
antibodi
titer
inde
laboratori
may
issu
guidelin
titer
antibodi
singl
serum
may
impli
recent
infect
practic
often
unreli
peak
antibodi
titer
seen
convalesc
stage
infect
vari
significantli
person
person
rapid
diagnosi
made
basi
singl
acutephas
serum
demonstr
virusspecif
antibodi
igm
class
igm
antibodi
appear
earli
infect
decreas
low
level
within
month
gener
disappear
altogeth
within
month
presenc
antibodi
indic
either
recent
chronic
infect
moreov
present
newborn
babi
antibodi
diagnost
intrauterin
infect
matern
igm
antibodi
unlik
igg
cross
placenta
immunoassay
describ
readili
render
igm
classspecif
eia
immunofluoresc
gener
use
typic
indirect
assay
virusspecif
igm
antibodi
depict
fig
particular
problem
igm
antibodi
assay
interfer
socal
rheumatoid
factor
antibodi
mainli
igm
class
direct
constant
region
fc
normal
igg
though
first
describ
rheumatoid
arthriti
autoimmun
diseas
rheumatoid
factor
fact
preval
mani
infecti
diseas
found
major
congenit
infect
neonat
rheumatoid
factor
produc
fals
posit
igm
immunoassay
bind
antivir
well
normal
igg
antibodi
human
serum
form
igmigg
complex
thu
antivir
igg
antibodi
sampl
also
bind
immobil
antigen
may
captur
rheumatoid
factor
present
turn
detect
antihuman
igm
antibodi
employ
detector
antibodi
assay
format
depict
lefthand
side
fig
order
minim
impact
rheumatoid
factor
advis
employ
revers
captur
igm
assay
fig
right
simplest
form
monoclon
antihuman
igm
use
captur
antibodi
label
viru
detectorind
commonli
unlabel
viru
detector
label
monoclon
antivir
igg
antibodi
perhap
better
still
f
antibodi
fragment
ad
indic
anoth
pitfal
igm
antibodi
assay
potenti
crossreact
close
relat
virus
antibodi
produc
earli
immun
respons
particularli
igm
antibodi
typic
broadli
react
b
cell
affin
matur
taken
place
exampl
infect
dengu
viru
may
produc
igm
antibodi
crossreact
number
relat
flavivirus
may
necessari
titrat
serum
panel
antigen
test
later
igg
sampl
identifi
particular
flaviviru
involv
falseneg
igm
result
occasion
encount
infant
respiratori
infect
reactiv
latent
herpesvirus
despit
pitfal
igm
antibodi
captur
assay
import
firstlin
diagnost
approach
infect
exampl
hepat
classspecif
immunoassay
also
design
measur
specif
antivir
antibodi
iga
ige
igg
class
given
igg
subclass
western
blot
allow
simultan
independ
detect
antibodi
number
differ
protein
present
particular
viru
prepar
simpler
configur
left
virusspecif
igm
antibodi
test
serum
react
viral
antigen
immobil
solid
phase
igm
antibodi
detect
label
antiigm
antibodi
configur
lead
falseposit
result
due
rheumatoid
factor
falseneg
result
due
block
compet
antivir
igg
antibodi
test
serum
altern
configur
right
igm
antibodi
captur
test
serum
immobil
antiigm
specif
antivir
igm
detect
progress
incub
viral
antigen
label
antivir
antibodi
enzymelabel
antibodi
larg
replac
label
antibodi
prefer
indic
system
four
key
step
western
blot
fig
first
concentr
viru
solubil
constitu
protein
separ
discret
band
accord
molecular
mass
r
sodium
dodecylsulfatepolyacrylamid
gel
electrophoresi
sdspage
second
separ
protein
electrophoret
transfer
blot
onto
nitrocellulos
sheet
order
immobil
separ
polypeptid
make
avail
reaction
antibodi
third
test
serum
allow
react
viral
protein
nitrocellulos
sheet
unbound
compon
wash
away
final
bound
antibodi
demonstr
use
enzymelabel
antispeci
antibodi
thu
immunoblot
permit
demonstr
antibodi
protein
given
viru
prepar
use
monitor
develop
antibodi
differ
antigen
differ
stage
infect
techniqu
play
crucial
role
ultim
confirmatori
test
sampl
give
initi
reaction
screen
eia
antihiv
antibodi
experi
taught
western
blot
pattern
like
repres
true
antihiv
antibodi
repres
like
falseposit
reaction
initi
eia
western
blot
also
import
research
tool
character
viral
antigen
mixtur
use
antibodi
reagent
rather
antigen
known
compon
reaction
serolog
test
use
mani
import
purpos
apart
diagnos
exclud
acut
chronic
infect
see
box
assay
valuabl
mani
context
provid
indic
clinic
subclin
infect
therebi
give
truer
record
total
number
infect
find
antibodi
viru
singl
sampl
carri
differ
clinic
implic
depend
viru
see
box
screen
immun
use
document
success
immun
individu
check
coverag
efficaci
vaccin
popul
addit
test
suscept
close
band
viral
protein
transfer
blot
onto
nitrocellulos
membran
capillari
transfer
usual
electrophoresi
differ
plane
immobil
polypeptid
unoccupi
area
membran
block
quench
satur
suitabl
protein
wash
dri
cut
strip
use
test
individu
patient
sera
test
serum
plasma
primari
antibodi
incub
one
strip
enabl
antibodi
bind
individu
viral
protein
follow
rins
bound
antibodi
detect
addit
enzymelabel
antihuman
immunoglobulin
secondari
antibodi
follow
anoth
wash
band
reveal
addit
substrat
chosen
produc
insolubl
color
product
techniqu
may
use
prepar
known
antigen
exampl
infect
cell
lysat
separ
gel
examin
serum
sampl
contain
unknown
antibodi
altern
known
antiserum
use
detect
antigen
unknown
sampl
react
run
gel
contact
individu
potenti
danger
infect
allow
protect
atrisk
nonimmun
individu
segreg
immun
provid
baselin
subsequ
monitor
cours
infect
interpret
perform
diagnost
assay
judg
two
essenti
criteria
specif
sensit
sensit
given
test
measur
percentag
diseas
infect
question
identifi
posit
test
exampl
particular
eia
use
screen
popul
hiv
antibodi
may
display
sensit
everi
infect
peopl
correctli
detect
miss
falseneg
rate
equal
contrast
specif
test
measur
percentag
without
diseas
infect
yield
neg
result
exampl
eia
hiv
antibodi
may
specif
everi
uninfect
peopl
correctli
diagnos
clear
incorrectli
score
infect
falseposit
rate
equal
wherea
sensit
specif
fix
percentag
intrins
particular
diagnost
assay
predict
valu
assay
greatli
affect
preval
diseas
infect
involv
thu
eia
use
screen
highrisk
popul
hiv
preval
predict
valu
assay
high
howev
use
screen
blood
donor
known
hiv
preval
great
major
regist
posit
fact
fals
posit
requir
followup
confirmatori
test
much
higher
specif
strike
illustr
draw
attent
import
select
diagnost
assay
particular
object
mind
test
high
sensit
requir
aim
screen
seriou
infect
diagnosi
must
miss
test
high
specif
also
requir
confirm
diagnosi
correct
sensit
given
immunoassay
realli
measur
abil
detect
small
amount
either
antibodi
antigen
instanc
eia
ria
neutral
assay
gener
display
substanti
higher
sensit
immun
electron
microscopi
immunofluoresc
older
serolog
method
complement
fixat
immunodiffus
improv
sensit
achiev
miniatur
assay
use
purifi
reagent
sensit
instrument
signal
amplif
hand
specif
immunoassay
measur
test
capac
discrimin
thu
influenc
mainli
puriti
key
reagent
antigen
test
antibodi
antibodi
test
antigen
use
clone
antigen
synthet
peptid
usual
improv
specif
antibodi
detect
note
use
signal
amplif
increas
sensit
test
like
also
increas
signal
due
background
falseposit
reaction
signal
nois
ratio
may
improv
isol
identif
particular
viru
demonstr
infect
serolog
method
patient
given
diseas
necessarili
relev
exampl
rate
new
hepat
c
infect
evalu
immun
program
exampl
measl
hepat
b
assess
level
herd
immun
exampl
influenza
assess
exposur
result
occup
lifestylewheth
certain
activ
associ
increas
rate
infect
use
agespecif
preval
pattern
analyz
transmiss
effici
possibl
transmiss
rout
exampl
agespecif
acquisit
ebv
antibodi
determin
whether
appar
new
infect
man
actual
alreadi
circul
subclin
search
anim
reservoir
appar
new
zoonot
infect
exampl
nonhuman
speci
show
antibodi
sar
ebola
virus
usual
approach
regard
unknown
biolog
specimen
potenti
infecti
appli
level
contain
appropri
major
agent
like
present
exampl
individu
sampl
known
suspect
case
greater
hazard
exampl
ebola
handl
higher
contain
level
identifi
similarli
materi
laboratori
wild
anim
particularli
primat
may
contain
unknown
pathogen
danger
human
contain
level
good
laboratori
techniqu
essenti
aspect
avoid
laboratori
hazard
use
elabor
safeti
equip
neg
air
pressur
manag
etc
compens
sloppi
unsaf
practic
rigor
asept
techniqu
must
practic
mouth
pipet
ban
laboratori
coat
must
worn
time
glove
must
use
handl
potenti
infecti
materi
special
care
taken
sharp
object
rigor
attent
must
given
steril
possibl
autoclav
potenti
infecti
wast
well
use
equip
special
arrang
dispos
sharp
essenti
spill
clean
appropri
chemic
disinfect
staff
immun
diseas
hepat
b
poliomyel
matter
routin
vaccin
avail
exot
agent
special
laboratori
handl
virus
limit
place
type
work
undertaken
pregnant
immunosuppress
employe
also
import
inactiv
infect
particularli
danger
virus
employ
antigen
serolog
test
viru
neutral
eg
arenavirus
rhabdovirus
togavirus
flavivirus
done
without
destroy
antigen
photodynam
inactiv
ultraviolet
light
presenc
psoralen
relat
compound
viral
protein
produc
recombin
dna
technolog
provid
simpl
standard
safe
altern
whole
viru
antigen
mani
serolog
test
